Logo image of BNN.DE

BRAIN BIOTECH AG (BNN.DE) Stock Price, Quote, News and Overview

FRA:BNN - Deutsche Boerse Ag - DE0005203947 - Common Stock - Currency: EUR

2.25  -0.08 (-3.43%)

BNN.DE Quote, Performance and Key Statistics

BRAIN BIOTECH AG

FRA:BNN (7/25/2025, 7:00:00 PM)

2.25

-0.08 (-3.43%)

Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals
Statistics
52 Week High4.4
52 Week Low1.42
Market Cap49.16M
Shares21.85M
Float9.07M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE891.09
Earnings (Next)08-28 2025-08-28
IPO02-09 2016-02-09


BNN.DE short term performance overview.The bars show the price performance of BNN.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30

BNN.DE long term performance overview.The bars show the price performance of BNN.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of BNN.DE is 2.25 EUR. In the past month the price increased by 14.8%. In the past year, price increased by 0.45%.

BRAIN BIOTECH AG / BNN Daily stock chart

BNN.DE Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
SIKA.DE SIKA AG-REG 26.86 35.82B
GIN.DE GIVAUDAN-REG 29.29 34.97B
6D81.DE DUPONT DE NEMOURS INC 17.44 26.79B
DSFIR.AS DSM-FIRMENICH AG 93.85 23.44B
BRG.OL BORREGAARD ASA 23.59 19.44B
ELK.OL ELKEM ASA 31.49 15.70B
SY1.DE SYMRISE AG 25.51 12.20B
1COV.DE COVESTRO AG N/A 11.43B
AKZA.AS AKZO NOBEL N.V. 15.5 9.98B
EVK.DE EVONIK INDUSTRIES AG 28.17 8.40B
AMC.DE ALBEMARLE CORP N/A 8.35B
SYENS.BR SYENSQO SA 15.01 7.41B

About BNN.DE

Company Profile

BNN logo image BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 285 full-time employees. The company went IPO on 2016-02-09. Biotechnology Research and Information Network AG, is a Germany -based Company. The firm is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.

Company Info

BRAIN BIOTECH AG

Darmstaedter Strasse 34-36

Zwingenberg HESSEN DE

Employees: 296

BNN Company Website

BNN Investor Relations

Phone: 49625193310

BRAIN BIOTECH AG / BNN.DE FAQ

What is the stock price of BRAIN BIOTECH AG today?

The current stock price of BNN.DE is 2.25 EUR. The price decreased by -3.43% in the last trading session.


What is the ticker symbol for BRAIN BIOTECH AG stock?

The exchange symbol of BRAIN BIOTECH AG is BNN and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is BNN.DE stock listed?

BNN.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for BRAIN BIOTECH AG stock?

9 analysts have analysed BNN.DE and the average price target is 5.83 EUR. This implies a price increase of 159.31% is expected in the next year compared to the current price of 2.25. Check the BRAIN BIOTECH AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BRAIN BIOTECH AG worth?

BRAIN BIOTECH AG (BNN.DE) has a market capitalization of 49.16M EUR. This makes BNN.DE a Nano Cap stock.


How many employees does BRAIN BIOTECH AG have?

BRAIN BIOTECH AG (BNN.DE) currently has 296 employees.


What are the support and resistance levels for BRAIN BIOTECH AG (BNN.DE) stock?

BRAIN BIOTECH AG (BNN.DE) has a support level at 1.92 and a resistance level at 2.6. Check the full technical report for a detailed analysis of BNN.DE support and resistance levels.


Is BRAIN BIOTECH AG (BNN.DE) expected to grow?

The Revenue of BRAIN BIOTECH AG (BNN.DE) is expected to grow by 6.32% in the next year. Check the estimates tab for more information on the BNN.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BRAIN BIOTECH AG (BNN.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BRAIN BIOTECH AG (BNN.DE) stock pay dividends?

BNN.DE does not pay a dividend.


When does BRAIN BIOTECH AG (BNN.DE) report earnings?

BRAIN BIOTECH AG (BNN.DE) will report earnings on 2025-08-28.


What is the Price/Earnings (PE) ratio of BRAIN BIOTECH AG (BNN.DE)?

BRAIN BIOTECH AG (BNN.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).


BNN.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to BNN.DE. When comparing the yearly performance of all stocks, BNN.DE is a bad performer in the overall market: 77.91% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BNN.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BNN.DE. Both the profitability and financial health of BNN.DE have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BNN.DE Financial Highlights

Over the last trailing twelve months BNN.DE reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS decreased by -69.73% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -17.27%
ROE -227.22%
Debt/Equity 0.74
Chartmill High Growth Momentum
EPS Q2Q%-59.45%
Sales Q2Q%-15.68%
EPS 1Y (TTM)-69.73%
Revenue 1Y (TTM)-4.88%

BNN.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to BNN.DE. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 70.76% and a revenue growth 6.32% for BNN.DE


Ownership
Inst Owners12.89%
Ins Owners53.72%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84.44
Price Target5.83 (159.11%)
EPS Next Y70.76%
Revenue Next Year6.32%